Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular heterogeneity in tumours.

M F Woodruff

    British Journal of Cancer
    |May 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Malignant tumors exhibit significant cellular heterogeneity, arising from diverse cell populations. This diversity impacts tumor progression, metastasis, and therapeutic responses, highlighting the complexity of cancer biology.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tumour-association transplantation antigens.

    Immunology today·2014
    Same author

    The Outlook for Transplantation of the Kidney in Man.

    Proceedings of the Royal Society of Medicine·2009
    Same author

    Tissue Transplantation.

    Proceedings of the Royal Society of Medicine·2009
    Same author

    Transplantation and cancer control: a lifetime of research.

    Proceedings of the Royal College of Physicians of Edinburgh·1992
    Same author

    Immunosurveillance.

    Current opinion in immunology·1989
    Same author

    The role of immunology in the development of clinical transplantation.

    Immunology letters·1989
    Same journal

    The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.

    British journal of cancer·2026
    Same journal

    Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

    British journal of cancer·2026
    Same journal

    Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

    British journal of cancer·2026
    Same journal

    Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

    British journal of cancer·2026
    Same journal

    De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

    British journal of cancer·2026
    Same journal

    Planetary Health Diet Index and breast cancer risk.

    British journal of cancer·2026
    See all related articles

    Area of Science:

    • Oncology
    • Cancer Biology
    • Cellular Heterogeneity

    Background:

    • Malignant tumors are complex ecosystems containing normal, transformed, initiated, and hybrid cells.
    • Tumor growth relies on the proliferation of clonogenic cells, a subset of transformed cell descendants.
    • These clonogenic cells display considerable variation in morphology, genetics, and functional properties.

    Purpose of the Study:

    • To explore the origins and implications of cellular heterogeneity in malignant tumors.
    • To understand how tumor cell population dynamics influence metastasis and recurrence.
    • To examine the impact of heterogeneity on therapeutic outcomes.

    Main Methods:

    • Review of existing evidence on tumor cell populations and heterogeneity.

    Related Experiment Videos

  • Analysis of factors contributing to phenotypic diversity within tumor clones.
  • Consideration of cell-cell interactions and their role in tumor kinetics.

    • Main Results:

    • Tumor heterogeneity arises from pleoclonal origins, intraclonal diversification, or hybridization.
    • Subpopulation selection is implicated in tumor metastasis and recurrence.
    • Heterogeneity influences drug sensitivity, immunogenicity, and host immune response.

    Conclusions:

    • Cellular heterogeneity is a fundamental characteristic of malignant tumors.
    • Understanding tumor heterogeneity is crucial for predicting treatment efficacy and failure.
    • Further research into tumor cell population dynamics is warranted for improved cancer therapies.